In Vivo CRO Market, By Indication (Blood Cancer, Solid Tumors and Other Indications), By Model (Syngeneic, Xenograft, Patient Derived Xenograft (PDX) and Other Models), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI482721 | Publish Date: May 2023 | No. of Pages: 165

Global In Vivo CRO Market Overview

Contract research organisations (CROs) that conduct biopharmaceutical research in vivo are known as in-vivo contract research organisations (IVCROs). With the increasing popularity of biologics over small molecule medications, in-vivo CROs are becoming more common. Due to the high level of competition in the development of mABs, CROs are focusing more on biosimilar development. The focus of the pipeline is changing away from regular format mABs and toward bispecifics or biosimilars. Integrated contract research, development, and manufacturing organisations (CDMOs) are expanding their revenue footprint across all areas as demand for clinical scale manufacture of active pharmaceutical components grows. Contract research organisations (CROs) that conduct biopharmaceutical research in vivo are known as in-vivo contract research organisations (IVCROs). With the increasing popularity of biologics over small molecule medications, in-vivo CROs are becoming more common. Due to the high level of competition in the development of mABs, CROs are focusing more on biosimilar development. The focus of the pipeline is changing away from regular format mABs and toward bispecifics or biosimilars. Integrated contract research, development, and manufacturing organisations (CDMOs) are expanding their revenue footprint across all areas as demand for clinical scale manufacture of active pharmaceutical components grows. The In Vivo CRO Market  accounted for US$ 3.29 billion in 2020 and is estimated to be US$ 6.77 billion by 2030 and is anticipated to register a CAGR of 7.50%.

Global In Vivo CRO Market Dynamics

Increase in the geriatric population will drive the growth of the Market

The growth of the oncology-based In-Vivo CRO market has also been fueled by an increase in the geriatric population. The number of late-stage pipeline therapies rose from 711 in 2017 to 849 in 2018 – a 19% increase – due to the increasing number of specific therapies in the oncology pipeline and the presence of a large number of pipeline drugs, and the use of oncology-based In-Vivo CROs aid in the development of novel therapies for the diagnosis, prevention, and treatment of patients, which are expected to further boost market growth. According to statistics accessible from government organisations around the world, cancer is one of the most studied indications, alongside the development of vaccines for infectious diseases. There are a few more factors that have been crucial in propelling the growth of the oncology based In-Vivo CRO market, including federal funding for research studies, increasing cancer treatment, and research expertise, all of which are expected to propel the oncology based In-Vivo CRO market to the next level.  According to data from the North American Association of Central Cancer Registries (NAACCR), there may be 176,2450 new cancer cases in the United States in 2019.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global In Vivo CRO Market Segmentation

 

                                                Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The Global In Vivo CRO Market is segmented based on indication, model and region.

On the basis of Indication, the Global In Vivo CRO Market is segmented into Blood Cancer, Solid Tumors and Other Indications. Based on Model, the target market is segmented into Syngeneic, Xenograft, Patient Derived Xenograft (PDX) and Other Models.

Regional Insights:

 

                                     

On region the Global In Vivo CRO Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. During the forecast period, throughout the projection period, North America is likely to dominate the worldwide oncology-based In-Vivo CRO market. This is due to a variety of important variables, including the increased frequency of cancer, the availability of advanced healthcare infrastructure, and the existence of a high number of CROs in the region. The United States holds the largest market share in the North American region, owing to factors such as the rising geriatric population, research and developments related to cancer therapy, and rising government initiatives for cancer awareness in the country, which are expected to further drive the oncology-based In-Vivo CRO market in this region.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Indication- Blood Cancer, Solid Tumors and Other Indications

By Model– Syngeneic, Xenograft, Patient Derived Xenograft (PDX) and Other Models

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global In Vivo CRO Market report based on Indication, Model and region.

Global  In Vivo CRO Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global In Vivo CRO Market Key Players

The key players operating in the in vivo CRO market are Pharmaceutical Product Development, LLC (PPD); Quintiles; ICON Plc; Parexel International; American Preclinical Services, LLC; Covance Inc.;Theorem Clinical research; WuXi AppTec, Inc.; inVentiv Health; Evotec (US), Inc.; and Charles River Laboratories.  The market for oncology-based In-Vivo CROs is moderately competitive, with many significant competitors. In terms of market share, the market is currently dominated by a few significant competitors. And some major corporations have been aggressively acquiring and forming joint ventures with other businesses in order to strengthen their market positions around the world.

Global In Vivo CRO Market Company Profile

  • Pharmaceutical Product Development, LLC (PPD)
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Quintiles
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • ICON Plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Parexel International
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • American Preclinical Services, LLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Covance Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Theorem Clinical research
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • WuXi AppTec, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Global In Vivo CRO Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for in vivo CRO Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Indication
      • Market Snippet, By Model
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global In Vivo CRO Market, By Indication, 2020 – 2030, (US$ Bn)
    • Overview         
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Blood Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Solid Tumor
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global In Vivo CRO Market, By Model, 2020 – 2030, (US$ Bn)
    • Overview                                                 
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Syngeneic
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Xenograft
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Patient Derived Xenograft (PDX)
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global In Vivo CRO Market, By Region, 2020 – 2030, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Model, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Model, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Model, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Model, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Model, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  9. Company Profiles
  • Pharmaceutical Product Development, LLC (PPD)
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Quintiles
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • ICON Plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Parexel International
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • American Preclinical Services, LLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Covance Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Theorem Clinical research
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • WuXi AppTec, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

Global In Vivo CRO Market is segmented based on indication, model and region.

Increase in the geriatric population is major factor driving the market.

During the forecast period, North America is expected to dominate the market.

The key players operating in the in vivo CRO market are Pharmaceutical Product Development, LLC (PPD); Quintiles; ICON Plc; Parexel International; American Preclinical Services, LLC; Covance Inc.;Theorem Clinical research; WuXi AppTec, Inc.; inVentiv Health; Evotec (US), Inc.; and Charles River Laboratories.